2000•Journal of Clinical Medical officerRequires access

Relationship between expression of P~(53) and PCNA and histologic types, clinical stage and prognosis in pulmonary adenocarcinoma

Jing Liu

Open publisher page 0 citations

Abstract

Objective to study the expression features of P 53 and PCNA in pulmonary adenocarcinoma and its correlation with histologic types, clinical stages and prognosis Method S P immunohistochemical staining was used in specimens of 60 cases with pulmonary adenocarcinoma Result The positive rate of expression of P 53 and PCNA was 51.7% and 81.7% respectively, positive expression of subtypes had not obvious difference positive expression rate(82.4%)of P 53 was higher in stage Ⅲ than in stage Ⅰ(33.3%)and in stage Ⅱ(45.4%) P 0.01 and P 0.05 Results of association detection of P 53 and PCNA showed higher uniformity(50.0%)and complementaity(90.0%) Conclusion Abnormal expression of P 53 is in close relationship to biologic behaviour of cancer cells and can be used to evaluate prognosis of lung cancer and demonstrate that mutative P 53 can derectly accelerate activity of PCNA

About this research paper

What this paper is about

Objective to study the expression features of P 53 and PCNA in pulmonary adenocarcinoma and its correlation with histologic types, clinical stages and prognosis Method S P immunohistochemical staining was used in specimens of 60 cases with pulmonary adenocarcinoma Result The positive rate of expression of P 53 and PCNA was 51.7% and 81.7% respectively, positive expression of subtypes had not obvious difference positive expression rate(82.4%)of P 53 was higher in stage Ⅲ than in stage Ⅰ(33.3%)and in stage Ⅱ(45.4%) P 0.01 and P 0.05 Results of association detection of P 53 and PCNA showed higher uniformity(50.0%)and complementaity(90.0%) Conclusion Abnormal expression of P 53 is in close relationship to biologic behaviour of cancer cells and can be used to evaluate prognosis of lung cancer and demonstrate that mutative P 53 can derectly accelerate activity of PCNA

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective to study the expression features of P 53 and PCNA in pulmonary adenocarcinoma and its correlation with histologic types, clinical stages and prognosis Method S P immunohistochemical staining was used in specimens of 60 cases with pulmonary adenocarcinoma Result The positive rate of expression of P 53 and PCNA was 51.7% and 81.7% respectively, positive expression of subtypes had not obvious difference positive expression rate(82.4%)of P 53 was higher in stage Ⅲ than in stage Ⅰ(33.3%)and in stage Ⅱ(45.4%) P 0.01 and P 0.05 Results of association detection of P 53 and PCNA showed higher uniformity(50.0%)and complementaity(90.0%) Conclusion Abnormal expression of P 53 is in close relationship to biologic behaviour of cancer cells and can be used to evaluate prognosis of lung cancer and demonstrate that mutative P 53 can derectly accelerate activity of PCNA

Key concepts: Proliferating cell nuclear antigen, Medicine, Immunohistochemistry, Adenocarcinoma, Stage (stratigraphy), Pulmonary adenocarcinoma, Lung cancer, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Relationship between expression of P~(53) and PCNA and histologic types, clinical stage and prognosis in pulmonary adenocarcinoma — Research Paper | ScholarLens